These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37022732)

  • 1. B-cell prolymphocytic leukemia after COVID-19 infection.
    Falini B; Lazzi S
    Blood; 2023 Apr; 141(14):1777. PubMed ID: 37022732
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax.
    Christoforidou A; Bezirgiannidou Z; Vrachiolias G; Papoutselis M; Spanoudakis E; Kotsianidis Ι
    Leuk Lymphoma; 2020 Mar; 61(3):749-752. PubMed ID: 31713446
    [No Abstract]   [Full Text] [Related]  

  • 4. Auer Rod-Like Inclusions in B-Cell Prolymphocytic Leukemia.
    Zhao Y; Lv J
    Turk J Haematol; 2019 Nov; 36(4):280-281. PubMed ID: 30238921
    [No Abstract]   [Full Text] [Related]  

  • 5. T-Cell Prolymphocytic Leukemia: Long-Term Remissions Challenging!
    Sellner L
    Acta Haematol; 2021; 144(1):4-5. PubMed ID: 32392564
    [No Abstract]   [Full Text] [Related]  

  • 6. B-cell prolymphocytic leukemia and chronic lymphocytic leukemia have distinctive gene expression signatures.
    Del Giudice I; Osuji N; Dexter T; Brito-Babapulle V; Parry-Jones N; Chiaretti S; Messina M; Morgan G; Catovsky D; Matutes E
    Leukemia; 2009 Nov; 23(11):2160-7. PubMed ID: 19641528
    [No Abstract]   [Full Text] [Related]  

  • 7. Auer Rod-Like Inclusions in Prolymphocytic Leukemia.
    Qiufan Z; Shumei X; Xifeng D; Shuwen D; Huaquan W; Zonghong S
    Clin Lab; 2015; 61(7):831-4. PubMed ID: 26299084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell prolymphocytic leukemia has 3 subsets.
    Kay NE; Hanson CA
    Blood; 2019 Nov; 134(21):1777-1778. PubMed ID: 31751477
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.
    Flatley E; Chen AI; Zhao X; Jaffe ES; Dunlap JB; Pittaluga S; Abdullah S; Olson SB; Spurgeon SE; Fan G
    Am J Clin Pathol; 2014 Sep; 142(3):347-54. PubMed ID: 25125625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of a cohort of 41
    Algrin C; Pérol L; Chapiro E; Baseggio L; Maloum K; Settegrana C; Lesesve JF; Siavellis J; Delmer A; Michallet AS; Ferrant E; Feugier P; Tomowiak C; Brion A; Ghez D; Fornecker LM; Ivanoff S; Struski S; Sutton L; Radford-Weiss I; Eclache V; Lefebvre C; Leblond V; Nguyen-Khac F; Roos-Weil D
    Haematologica; 2023 Jun; 108(6):1691-1696. PubMed ID: 36546425
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent chronic lymphocytic leukemia and prolymphocytic leukemia derived from two separate B-cell clones.
    Cao F; Amato D; Wang C
    Am J Hematol; 2011 Sep; 86(9):782. PubMed ID: 21465516
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial treatment of B-cell prolymphocytic leukemia with ibrutinib.
    Moore J; Baran AM; Meacham PJ; Evans AG; Barr PM; Zent CS
    Am J Hematol; 2020 May; 95(5):E108-E110. PubMed ID: 31951033
    [No Abstract]   [Full Text] [Related]  

  • 13. Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
    Eyre TA; Fox CP; Shankara P; Went R; Schuh AH
    Br J Haematol; 2017 May; 177(3):486-491. PubMed ID: 27061924
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of B-cell prolymphocytic leukemia in a patient with splenic diffuse red pulp small B-cell lymphoma.
    Cheng WY; Zhu YM; Cheng S; Chen YS; Shen Y
    Leuk Lymphoma; 2018 Aug; 59(8):1990-1993. PubMed ID: 29199492
    [No Abstract]   [Full Text] [Related]  

  • 15. Hot and Cold: A Concurrent Warm and Cold Autoimmune Hemolytic Anemia in B-cell Prolymphocytic Leukemia.
    Feld J; Arnason J; O Apos Brien K; Nahas M
    Acta Haematol; 2019; 141(4):222-224. PubMed ID: 30947164
    [No Abstract]   [Full Text] [Related]  

  • 16. B-prolymphocytic leukemia: Is it time to retire this entity?
    El Hussein S; Khoury JD; Medeiros LJ
    Ann Diagn Pathol; 2021 Oct; 54():151790. PubMed ID: 34293709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B and T cell prolymphocytic leukaemia.
    Cross M; Dearden C
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CD5-positive B-cell prolymphocytic leukemia].
    Inoue T; Yoshida M; Oowashi K; Yoshida T
    Rinsho Ketsueki; 2010 Jan; 51(1):80-2. PubMed ID: 20134145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smudge cells following treatment with pentostatin in a patient with B-cell prolymphocytic leukemia.
    Yun HD; Waller EK
    Blood; 2013 Jul; 122(4):474. PubMed ID: 24049774
    [No Abstract]   [Full Text] [Related]  

  • 20. De novo B-cell prolymphocytic leukemia with central nervous system involvement.
    Tatarczuch M; Blombery P; Seymour JF
    Leuk Lymphoma; 2014 Jul; 55(7):1665-7. PubMed ID: 24047478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.